Mrsa clinical trials

Explore recruiting mrsa clinical trials.

Recruiting mrsa studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mrsa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of the decolonization rate and acceptance of a complete nasal decolonization kit with povidone iodine for MRSA patients (MRSAD-PVP-I)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dose and Duration in critically ill patients

Netherlands, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized placebo-controlled double-blinded trial of the treatment of MRSA throat carriage with either standard decolonization therapy or standard decolonization therapy combined with oral clindamycin

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A non-commercial, randomized, open-label clinical trial to evaluate the efficacy of 1.8-cineole compared to mupirocin in the treatment of chronic rhinitis caused by carriage of methicillin-resistant Staphylococcus aureus (NOSE)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in cystic fibrosis patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol - A multi-national pharmacokinetic/pharmacodynamic cohort study to determine whether contemporary antibiotic dosing for critically ill patients achieves therapeutic exposures.

France

Therapeutic use (Phase IV) EU CTIS Study details

Mrsa trials by city

Mrsa in Toronto Mrsa in Vancouver Mrsa in Montreal Mrsa in Calgary Mrsa in Edmonton Mrsa in Ottawa Mrsa in Winnipeg Mrsa in Quebec City Mrsa in Hamilton Mrsa in Kitchener Mrsa in London Mrsa in Halifax Mrsa in New York Mrsa in Los Angeles Mrsa in Chicago Mrsa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease